{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:12:28Z","timestamp":1790791948064,"version":"4.1.0"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"crossref","award":["RSPD2024R1035"],"award-info":[{"award-number":["RSPD2024R1035"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-81711-5","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T08:29:54Z","timestamp":1735979394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring pyrazolines as potential inhibitors of NSP3-macrodomain of SARS-CoV-2: synthesis and in silico analysis"],"prefix":"10.1038","volume":"15","author":[{"given":"Rekha","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Soge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Alshammari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah A.","family":"Albekairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Yashwante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baban","family":"Kolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Lokhande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan J","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"1","key":"81711_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jiph.2022.11.024","volume":"16","author":"K Dhama","year":"2023","unstructured":"Dhama, K. et al. Global emerging omicron variant of SARS-CoV-2: impacts, challenges and strategies. J. Infect. Public. Health  16 (1), 4\u201314 (2023).","journal-title":"J. Infect. Public. Health"},{"key":"81711_CR2","doi-asserted-by":"crossref","unstructured":"Chea, C. et al. Macrodomain Mac1 of SARS-CoV-2 nonstructural protein 3 hydrolyzes diverse ADP-ribosylated substrates. bioRxiv (2023).","DOI":"10.1101\/2023.02.07.527501"},{"issue":"5","key":"81711_CR3","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1080\/07391102.2022.2026818","volume":"41","author":"YO Ayipo","year":"2023","unstructured":"Ayipo, Y. O. et al. Molecular modelling and structure-activity relationship of a natural derivative of o-hydroxybenzoate as a potent inhibitor of dual NSP3 and NSP12 of SARS-CoV-2: in silico study. J. Biomol. Struct. Dyn. 41 (5), 1959\u20131977 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"3","key":"81711_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1055\/s-0041-1725143","volume":"8","author":"A Khodavirdipour","year":"2021","unstructured":"Khodavirdipour, A. et al. Concise update on genomics of COVID-19: Approach to its latest mutations, escalated contagiousness, and vaccine resistance. Glob. Med. Genet. 8 (3), 85\u201389 (2021).","journal-title":"Glob Med. Genet."},{"key":"81711_CR5","doi-asserted-by":"crossref","unstructured":"Qin, B. et al. Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target. Nat. Commun., 14 (2023).","DOI":"10.1038\/s41467-023-39709-6"},{"issue":"2","key":"81711_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/pathogens12020324","volume":"12","author":"M Schuller","year":"2023","unstructured":"Schuller, M. et al. Discovery and Development Strategies for SARS-CoV-2 NSP3 macrodomain inhibitors. Pathogens 12 (2), 324 (2023).","journal-title":"Pathogens"},{"key":"81711_CR7","doi-asserted-by":"crossref","unstructured":"Correy, G. J. et al. The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature. Sci. Adv. 8  (21) (2022).","DOI":"10.1126\/sciadv.abo5083"},{"issue":"1","key":"81711_CR8","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei, X. et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 11 (1), 3810 (2020).","journal-title":"Nat. Commun."},{"key":"81711_CR9","doi-asserted-by":"crossref","unstructured":"Alhammad, Y. M. et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice. Proc. Natl. Acad. Sci. U. S. A. 120(35) (2023).","DOI":"10.1073\/pnas.2302083120"},{"issue":"3","key":"81711_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s41061-023-00422-z","volume":"381","author":"R Kumar","year":"2023","unstructured":"Kumar, R. et al. Synthetic approaches, Biological activities, and structure-activity relationship of pyrazolines and related derivatives. Top. Curr. Chem. (Cham.) 381 (3), 12 (2023).","journal-title":"Top. Curr. Chem. (Cham)"},{"key":"81711_CR11","doi-asserted-by":"publisher","first-page":"46999","DOI":"10.1039\/C7RA08939B","volume":"7","author":"B Varghese","year":"2017","unstructured":"Varghese, B. et al. Unveiling a versatile heterocycle: pyrazoline - a review. RSC Adv. 7, 46999\u201347016 (2017).","journal-title":"RSC Adv."},{"key":"81711_CR12","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ejmech.2010.01.009","volume":"45","author":"T Chandra","year":"2010","unstructured":"Chandra, T. Synthesis of substituted acridinyl pyrazoline derivatives and their evaluation for anti-inflammatory activity. Eur. J. Med. Chem. 45, 1772\u20131776 (2010).","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"81711_CR13","doi-asserted-by":"publisher","first-page":"19066","DOI":"10.3390\/molecules201019066","volume":"20","author":"M Karabacak","year":"2015","unstructured":"Karabacak, M. et al. Synthesis and evaluation of new pyrazoline derivatives as potential anticancer agents. Molecules 20 (10), 19066\u201319084 (2015).","journal-title":"Molecules"},{"key":"81711_CR14","first-page":"1958","volume":"9","author":"B Ardiansah","year":"2017","unstructured":"Ardiansah, B. Pharmaceutical importance of pyrazoline derivatives: a mini review. J. Pharm. Sci. Res. 9, 1958\u20131960 (2017).","journal-title":"J. Pharm. Sci. Res."},{"key":"81711_CR15","doi-asserted-by":"publisher","first-page":"112666","DOI":"10.1016\/j.ejmech.2020.112666","volume":"205","author":"B Nehra","year":"2020","unstructured":"Nehra, B. et al. Recent advancements in the development of bioactive pyrazoline derivatives. Eur. J. Med. Chem. 205, 112666 (2020).","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"81711_CR16","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.3390\/ijms21155507","volume":"21","author":"D Matiadis","year":"2020","unstructured":"Matiadis, D. & Sagnou, M. Pyrazoline hybrids as promising anticancer agents: an up-to-date overview. Int. J. Mol. Sci. 21 (15), 5507 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"81711_CR17","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1021\/acsomega.1c06694","volume":"7","author":"R Mehmood","year":"2022","unstructured":"Mehmood, R. et al. Synthesis and evaluation of 1,3,5-Triaryl-2-pyrazoline derivatives as potent dual inhibitors of urease and a-glucosidase together with their cytotoxic, molecular modeling and drug-likeness studies. ACS Omega  7 (4), 3775\u20133795 (2022).","journal-title":"ACS Omega"},{"key":"81711_CR18","doi-asserted-by":"crossref","unstructured":"Moon, P. et al. Discovery of potent pyrazoline-based covalent SARS-CoV-2 main protease inhibitors. Chembiochem 24(11), e202300116 (2023).","DOI":"10.1002\/cbic.202300116"},{"issue":"22","key":"81711_CR19","doi-asserted-by":"publisher","first-page":"12951","DOI":"10.1080\/07391102.2023.2169765","volume":"41","author":"S Akman","year":"2023","unstructured":"Akman, S. et al. Density functional modeling, and molecular docking with SARS-CoV-2 spike protein (Wuhan) and omicron S protein (variant) studies of new heterocyclic compounds including a pyrazoline nucleus. J. Biomol. Struct. Dyn. 41 (22), 12951\u201312965 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"81711_CR20","doi-asserted-by":"publisher","first-page":"109120","DOI":"10.1016\/j.steroids.2022.109120","volume":"188","author":"Shahabuddin","year":"2022","unstructured":"Shahabuddin et al. Reaction of 7\u03b1-bromo-6-nitrocholest-5-enes with hydrazine: formation of steroidal pyrazolines and molecular docking against SARS-CoV-2 omicron protease. Steroids 188, 109120 (2022).","journal-title":"Steroids"},{"issue":"16","key":"81711_CR21","doi-asserted-by":"publisher","first-page":"eabf8711","DOI":"10.1126\/sciadv.abf8711","volume":"7","author":"M Schuller","year":"2021","unstructured":"Schuller, M. et al. Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking. Sci. Adv. 7 (16), eabf8711 (2021).","journal-title":"Sci. Adv."},{"key":"81711_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1860-5397-3-13","volume":"3","author":"JT Li","year":"2007","unstructured":"Li, J. T., Zhang, X. H. & Lin, Z. P. An improved synthesis of 1,3,5-triaryl-2-pyrazolines in acetic acid aqueous solution under ultrasound irradiation. Beilstein J. Org. Chem. 3, 13 (2007).","journal-title":"Beilstein J. Org. Chem."},{"issue":"1","key":"81711_CR23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/molecules23010134","volume":"23","author":"K Karrouchi","year":"2018","unstructured":"Karrouchi, K. et al. Synthesis and pharmacological activities of pyrazole derivatives: a review. Molecules 23 (1), 134 (2018).","journal-title":"Molecules"},{"issue":"18","key":"81711_CR24","doi-asserted-by":"publisher","first-page":"8142","DOI":"10.1021\/jo301497g","volume":"77","author":"TA Nigst","year":"2012","unstructured":"Nigst, T. A., Antipova, A. & Mayr, H. Nucleophilic reactivities of hydrazines and amines: the futile search for the a-effect in hydrazine reactivities. J. Org. Chem. 77 (18), 8142\u20138155 (2012).","journal-title":"J. Org. Chem."},{"key":"81711_CR25","first-page":"351","volume":"49B","author":"R Gupta","year":"2010","unstructured":"Gupta, R., Gupta, N. & Jain, A. Improved synthesis of chalcones and pyrazolines under ultrasonic irradiation. Indian J. Chem. 49B, 351 (2010).","journal-title":"Indian J. Chem."},{"key":"81711_CR26","first-page":"135","volume":"3","author":"M Kidwai","year":"2006","unstructured":"Kidwai, M., Kukreja, S. & Thakur, R. K2CO3-Mediated regioselective synthesis of isoxazoles and pyrazolines Lett. Org. Chem. 3, 135 (2006).","journal-title":"Org. Chem."},{"key":"81711_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s12039-010-0093-9","volume":"122","author":"MAH Zahran","year":"2010","unstructured":"Zahran, M. A. H. et al. Efficient microwave irradiation enhanced stereoselective synthesis and antitumor activity of indolylchalcones and their pyrazoline analogs. J. Chem. Sci. 122, 587\u2013595 (2010).","journal-title":"J. Chem. Sci."},{"key":"81711_CR28","first-page":"334","volume":"56B","author":"A Goyal","year":"2017","unstructured":"Goyal, A., Sharma, S. & Gaba, J. Microwave assisted synthesis of some novel pyrazoline derivatives as potential antifungal agents. Indian J. Chem. 56B, 334 (2017).","journal-title":"Indian J. Chem."},{"key":"81711_CR29","first-page":"1310","volume":"41B","author":"V Malhotra","year":"2002","unstructured":"Malhotra, V. et al. Substituted imidazole derivatives as novel cardiovascular agents. Indian J. Chem. 41B, 1310 (2002).","journal-title":"Indian J. Chem."},{"key":"81711_CR30","first-page":"317","volume":"56B","author":"AK Tiwari","year":"2017","unstructured":"Tiwari, A. K. et al. Synthesis, characterization and in vitro antimicrobial activity of some novel 4, 5-dihydro-1H-pyrazoline derivatives. Indian J. Chem. 56B, 317 (2017).","journal-title":"Indian J. Chem."},{"key":"81711_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2174\/1876214X01003010079","volume":"3","author":"RH Fazaeli","year":"2010","unstructured":"Fazaeli, R. H. Highly efficient catalysts for the synthesis of Novel 1,3,5- triaryl-2-Pyrazoline derivatives. Open Catal. J. 3, 79 (2010).","journal-title":"Open. Catal. J."},{"key":"81711_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/2213346103666151203203139","volume":"3","author":"S Paul","year":"2016","unstructured":"Paul, S., Pradhan, K. & Das, A. R. Ethyl lactate as a green solvent: a promising bio-compatible media for organic synthesis. Green. Chem. 3, 111 (2016).","journal-title":"Green. Chem."},{"key":"81711_CR33","first-page":"568","volume":"45B","author":"B Holla","year":"2002","unstructured":"Holla, B. & Mahalinga, M. Synthesis of pyrazolines promoted by amberlyst-15 catalyst. Indian J. Chem. 45B, 568 (2002).","journal-title":"Indian J. Chem."},{"key":"81711_CR34","first-page":"1810","volume":"9","author":"S Sridhar","year":"2012","unstructured":"Sridhar, S. & Rajendraprasad, Y. Synthesis and analgesic studies of some New 2 pyrazolines. E J. Chem. 9, 1810 (2012).","journal-title":"E-J. Chem."},{"key":"81711_CR35","doi-asserted-by":"crossref","unstructured":"Bhat, P., Shridhar, G., Ladage, S. & Ravishankar, L. An eco-friendly synthesis of 2-pyrazoline derivatives catalysed by CeCl3\u00b77H2O. J. Chem. Sci. 129,1441 (2017).","DOI":"10.1007\/s12039-017-1327-x"},{"key":"81711_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3390\/ijerph5030139","volume":"5","author":"N Uzma","year":"2008","unstructured":"Uzma, N. et al. Impact of Organic solvents and Environmental pollutants on the Physiological Function in petrol filling workers.Int. J. Environ. Res. Public. Health 5, 139 (2008).","journal-title":"J. Environ. Res. Public. Health"},{"key":"81711_CR37","first-page":"2338","volume":"44B","author":"PD Lokhande","year":"2005","unstructured":"Lokhande, P. D., Waghmare, B. Y. & Sakate, S. S. Regioselective one-pot synthesis of 3,5-diarylpyrazoles. Indian J. Chem. 44B, 2338\u20132342 (2005).","journal-title":"Indian J. Chem."},{"issue":"4","key":"81711_CR38","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1080\/07391102.2019.1597770","volume":"38","author":"RJ Meshram","year":"2020","unstructured":"Meshram, R. J. et al. Known compounds and new lessons: structural and electronic basis of flavonoid-based bioactivities. J. Biomol. Struct. Dyn. 38 (4), 1168\u20131184 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"5","key":"81711_CR39","first-page":"KF01","volume":"11","author":"RJ Meshram","year":"2017","unstructured":"Meshram, R. J. et al. Pharmacophore mapping approach for drug target identification: a chemical synthesis and in silico study on novel thiadiazole compounds. J. Clin. Diagn. Res. 11 (5), KF01\u2013KF08 (2017).","journal-title":"J. Clin. Diagn. Res."},{"issue":"4","key":"81711_CR40","doi-asserted-by":"publisher","first-page":"150","DOI":"10.6026\/97320630005150","volume":"5","author":"RJ Meshram","year":"2010","unstructured":"Meshram, R. J. et al. Sequence analysis and homology modeling of laccase from pycnoporus cinnabarinus. Bioinformation 5 (4), 150\u2013154 (2010).","journal-title":"Bioinformation"},{"issue":"2","key":"81711_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s13205-019-1581-3","volume":"9","author":"KK Patil","year":"2019","unstructured":"Patil, K. K. et al. Dietary flavonoids inhibit the glycation of lens proteins: implications in the management of diabetic cataract. 3 Biotech. 9 (2), 47 (2019).","journal-title":"3 Biotech."},{"issue":"21","key":"81711_CR42","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1021\/ja204075s","volume":"133","author":"KR Cousins","year":"2011","unstructured":"Cousins, K. R. Computer review of ChemDraw Ultra 12.0. J. Am. Chem. Soc. 133 (21), 8388 (2011).","journal-title":"J. Am. Chem. Soc."},{"key":"81711_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open babel: an open chemical toolbox. J. Cheminform. 3, 33 (2011).","journal-title":"J. Cheminform"},{"key":"81711_CR44","doi-asserted-by":"publisher","first-page":"10024","DOI":"10.1021\/ja00051a040","volume":"114","author":"AK Rappe","year":"1992","unstructured":"Rappe, A. K. et al. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J. Am. Chem. Soc. 114, 10024\u201310039 (1992).","journal-title":"J. Am. Chem. Soc."},{"key":"81711_CR45","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","volume":"1263","author":"S Dallakyan","year":"2015","unstructured":"Dallakyan, S. & Olson, A. J. Small-molecule library screening by docking with PyRx. Methods Mol. Biol. 1263, 243\u2013250 (2015).","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"81711_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bib\/2.2.195","volume":"2","author":"W Kaplan","year":"2001","unstructured":"Kaplan, W. & Littlejohn, T. G. Swiss-PDB viewer (deep view). Brief. Bioinform. 2 (2), 195\u2013197 (2001).","journal-title":"Brief. Bioinform"},{"issue":"6","key":"81711_CR47","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/jcc.20634","volume":"28","author":"R Huey","year":"2007","unstructured":"Huey, R. et al. A semiempirical free energy force field with charge-based desolvation. J. Comput. Chem. 28 (6), 1145\u20131152 (2007).","journal-title":"J. Comput. Chem."},{"issue":"16","key":"81711_CR48","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30 (16), 2785\u20132791 (2009).","journal-title":"J. Comput. Chem."},{"issue":"3","key":"81711_CR49","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s11030-020-10129-8","volume":"25","author":"RJ Meshram","year":"2021","unstructured":"Meshram, R. J. et al. Modeling and simulation study to identify threonine synthase as possible drug target in leishmania major. Mol. Divers. 25 (3), 1679\u20131700 (2021).","journal-title":"Mol. Divers."},{"issue":"4","key":"81711_CR50","doi-asserted-by":"publisher","first-page":"044130","DOI":"10.1063\/5.0014475","volume":"153","author":"JC Phillips","year":"2020","unstructured":"Phillips, J. C. et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153 (4), 044130 (2020).","journal-title":"J. Chem. Phys."},{"issue":"18","key":"81711_CR51","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1021\/jp973084f","volume":"102","author":"AD MacKerell","year":"1998","unstructured":"MacKerell, A. D. et al. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J. Phys. Chem. B 102 (18), 3586\u20133616 (1998).","journal-title":"J. Phys. Chem. B"},{"issue":"11","key":"81711_CR52","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/jcc.20065","volume":"25","author":"AD Mackerell","year":"2004","unstructured":"Mackerell, A. D., Jr, Feig, M. & Brooks, C. L. 3rd Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J. Comput. Chem. 25 (11), 1400\u20131415 (2004).","journal-title":"J. Comput. Chem."},{"issue":"11","key":"81711_CR53","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete, V. et al. SwissParam: a fast force field generation tool for small organic molecules. J. Comput. Chem. 32 (11), 2359\u20132368 (2011).","journal-title":"J. Comput. Chem."},{"issue":"15","key":"81711_CR54","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1021\/acs.jcim.3c00658","volume":"63","author":"M Spivak","year":"2023","unstructured":"Spivak, M. et al. VMD as a platform for interactive small molecule preparation and visualization in quantum and classical simulations. J. Chem. Inf. Model. 63 (15), 4664\u20134678 (2023).","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"81711_CR55","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. GROMACS 4.5: a high-throughput and highly parallel open-source molecular simulation toolkit. Bioinformatics 29 (7), 845\u2013854 (2013).","journal-title":"Bioinformatics"},{"issue":"8","key":"81711_CR56","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/bioinformatics\/btaa774","volume":"37","author":"A Pedretti","year":"2021","unstructured":"Pedretti, A. et al. The VEGA suite of programs: an versatile platform for cheminformatics and drug design projects. Bioinformatics 37 (8), 1174\u20131175 (2021).","journal-title":"Bioinformatics"},{"issue":"14","key":"81711_CR57","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1093\/bioinformatics\/btw215","volume":"32","author":"H Liu","year":"2016","unstructured":"Liu, H. & Hou, T. CaFE: a tool for binding affinity prediction using end-point free energy methods. Bioinformatics 32 (14), 2216\u20132218 (2016).","journal-title":"Bioinformatics"},{"key":"81711_CR58","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J. Med. Chem. 49, 6177\u20136196 (2006).","journal-title":"J. Med. Chem."},{"issue":"1","key":"81711_CR59","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27 (1), 112\u2013128 (2018).","journal-title":"Protein Sci."},{"issue":"16","key":"81711_CR60","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang, E. et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem. Rev. 119 (16), 9478\u20139508 (2019).","journal-title":"Chem. Rev."},{"issue":"12","key":"81711_CR61","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2174\/138945008786949360","volume":"9","author":"HL de Amorim","year":"2008","unstructured":"de Amorim, H. L., Caceres, R. A. & Netz, P. A. Linear interaction energy (LIE) method in lead discovery and optimization. Curr. Drug Targets 9 (12), 1100\u20131105 (2008).","journal-title":"Curr. Drug Targets"},{"key":"81711_CR62","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J. et al. The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins 79, 2794\u20132812 (2011).","journal-title":"Proteins"},{"key":"81711_CR63","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"3","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 3, 7:42717 (2017).","journal-title":"Sci. Rep."},{"issue":"3","key":"81711_CR64","doi-asserted-by":"publisher","first-page":"e0300035","DOI":"10.1371\/journal.pone.0300035","volume":"19","author":"TA Majrashi","year":"2024","unstructured":"Majrashi, T. A. et al. DFT and molecular simulation validation of the binding activity of PDE\u03b4 inhibitors for repression of oncogenic k-Ras. PLoS ONE 19 (3), e0300035 (2024).","journal-title":"PLoS One"},{"issue":"1","key":"81711_CR65","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1038\/s41598-024-55046-0","volume":"14","author":"MI Serag","year":"2024","unstructured":"Serag, M. I. et al. New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study. Sci. Rep. 14 (1), 5474 (2024).","journal-title":"Sci. Rep."},{"key":"81711_CR66","doi-asserted-by":"crossref","unstructured":"Drwal, M. N. et al. ProTox: a web server for the in silico prediction of rodent oral toxicity. Nucleic Acids Res. 42 W53\u201358 (2014).","DOI":"10.1093\/nar\/gku401"},{"key":"81711_CR67","doi-asserted-by":"publisher","first-page":"105344","DOI":"10.1016\/j.antiviral.2022.105344","volume":"203","author":"A Roy","year":"2022","unstructured":"Roy, A. et al. Discovery of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding by high-throughput screening. Antiviral Res. 203, 105344 (2022).","journal-title":"Antiviral Res."},{"issue":"7","key":"81711_CR68","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.tim.2017.11.011","volume":"26","author":"AR Fehr","year":"2018","unstructured":"Fehr, A. R., Jankevicius, G., Ahel, I. & Perlman, S. Viral macrodomains: Unique mediators of viral replication and pathogenesis. Trends Microbiol. 26 (7), 598\u2013610 (2018).","journal-title":"Trends Microbiol."},{"key":"81711_CR69","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1107\/S2052252520009653","volume":"7","author":"K Michalska","year":"2020","unstructured":"Michalska, K. et al. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes. IUCrJ 7, 814\u2013824 (2020).","journal-title":"IUCrJ"},{"issue":"2","key":"81711_CR70","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31 (2), 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"issue":"2","key":"81711_CR71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/ijms17020144","volume":"17","author":"X Du","year":"2016","unstructured":"Du, X. Insights into protein-ligand interactions: mechanisms, models, and methods. Int. J. Mol. Sci. 17 (2), 144 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"81711_CR72","doi-asserted-by":"crossref","unstructured":"Blue, T. C. & Davis, K. M. Computational approaches: An underutilized tool in the quest to elucidate radical SAM dynamics. Molecules  26 (9), 2590 (2021).","DOI":"10.3390\/molecules26092590"},{"issue":"4","key":"81711_CR73","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/07391102.2021.2017352","volume":"41","author":"NP Tiwari","year":"2023","unstructured":"Tiwari, N. P., Pandey, J. P. & Pandey, D. M. Protein-protein docking and molecular dynamics studies of sericin and cocoonase of silkworm: an insight for cocoon softening. J. Biomol. Struct. Dyn. 41 (4), 1193\u20131205 (2023).","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"81711_CR74","doi-asserted-by":"publisher","first-page":"7483","DOI":"10.1038\/s41598-022-11100-3","volume":"12","author":"M Nouri Barkestani","year":"2022","unstructured":"Nouri Barkestani, M. et al. Optimization of IL-1RA structure to achieve a smaller protein with a higher affinity to its receptor. Sci. Rep. 12 (1), 7483 (2022).","journal-title":"Sci. Rep."},{"key":"81711_CR75","doi-asserted-by":"publisher","first-page":"1318797","DOI":"10.3389\/fphar.2024.1318797","volume":"15","author":"RA Baba","year":"2024","unstructured":"Baba, R. A. et al. Quercetin suppresses ROS production and migration by specifically targeting Rac1 activation in gliomas. Front. Pharmacol. 15, 1318797 (2024).","journal-title":"Front. Pharmacol."},{"key":"81711_CR76","doi-asserted-by":"publisher","first-page":"1339891","DOI":"10.3389\/fchem.2024.1339891","volume":"12","author":"AA Alzain","year":"2024","unstructured":"Alzain, A. A. et al. Integrating computational methods guided the discovery of phytochemicals as potential Pin1 inhibitors for cancer: pharmacophore modeling, molecular docking, MM-GBSA calculations and molecular dynamics studies. Front. Chem. 12, 1339891 (2024).","journal-title":"Front. Chem."},{"issue":"9","key":"81711_CR77","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1039\/D4RA00007B","volume":"14","author":"D Xie","year":"2024","unstructured":"Xie, D. et al. Design, synthesis, and inhibitory activity of hydroquinone ester derivatives against mushroom tyrosinase. RSC Adv. 14 (9), 6085\u20136095 (2024).","journal-title":"RSC Adv."},{"key":"81711_CR78","first-page":"1","volume":"17","author":"DL Aulifa","year":"2024","unstructured":"Aulifa, D. L. et al. Elucidation of molecular interactions between drug-polymer in amorphous solid dispersion by a computational approach using molecular dynamics simulations. Adv. Appl. Bioinform Chem. 17, 1\u201319 (2024).","journal-title":"Adv. Appl. Bioinform Chem."},{"issue":"2","key":"81711_CR79","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/ph17020163","volume":"17","author":"M Gackowski","year":"2024","unstructured":"Gackowski, M. et al. Novel thiourea and oxime ether isosteviol-based anticoagulants: MD simulation and ADMET prediction. Pharmaceuticals (Basel)  17 (2), 163 (2024).","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"81711_CR80","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden, S. & Ryde, U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin. Drug Discov.  10 (5), 449\u2013461 (2015).","journal-title":"Expert Opin. Drug Discov May"},{"issue":"1","key":"81711_CR81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","volume":"24","author":"T Hou","year":"2011","unstructured":"Hou, T. et al. Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations. J. Chem. Inf. Model.  24 (1), 69\u201382 (2011).","journal-title":"J. Chem. Inf. Model. Jan"},{"issue":"5","key":"81711_CR82","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1021\/ci300064d","volume":"25","author":"J Wang","year":"2012","unstructured":"Wang, J. & Hou, T. Develop and test a solvent accessible surface area-based model in conformational entropy calculations. J. Chem. Inf. Model. 25 (5), 1199\u20131212 (2012).","journal-title":"J. Chem. Inf. Model. May"},{"issue":"40","key":"81711_CR83","doi-asserted-by":"publisher","first-page":"22035","DOI":"10.1039\/C4CP03179B","volume":"28","author":"H Sun","year":"2014","unstructured":"Sun, H. et al. Assessing the performance of MM\/PBSA and MM\/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM\/GBSA and MM\/PBSA rescoring. Phys. Chem. Chem. Phys. Oct. 28 (40), 22035\u201322045 (2014).","journal-title":"Phys. Chem. Chem. Phys. Oct."},{"issue":"W1","key":"81711_CR84","doi-asserted-by":"publisher","first-page":"W367","DOI":"10.1093\/nar\/gkw315","volume":"44","author":"D Piovesan","year":"2016","unstructured":"Piovesan, D., Minervini, G. & Tosatto, S. C. The RING 2.0 web server for high quality residue interaction networks. Nucleic Acids Res. 44 (W1), W367\u2013W374 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"81711_CR85","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1039\/C9QO00342H","volume":"6","author":"K DeFrees","year":"2019","unstructured":"DeFrees, K. et al. An empirical study of amide-heteroarene p-stacking interactions using reversible inhibitors of a bacterial serine hydrolase. Org. Chem. Front. 6 (11), 1749\u20131756 (2019).","journal-title":"Org. Chem. Front."},{"issue":"4","key":"81711_CR86","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/anie.200804695","volume":"48","author":"LM Salonen","year":"2009","unstructured":"Salonen, L. M. et al. Cation-pi interactions at the active site of factor xa: dramatic enhancement upon stepwise N-alkylation of ammonium ions. Angew Chem. Int. Ed. Engl. 48 (4), 811\u2013814 (2009).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"81711_CR87","doi-asserted-by":"crossref","unstructured":"Salonen, L. M. et al. Molecular recognition at the active site of factor Xa: cation-p interactions, stacking on planar peptide surfaces, and replacement of structural water (2012).","DOI":"10.1002\/chem.201102571"},{"key":"81711_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1039\/B614208G","volume":"37","author":"BL Schottel","year":"2008","unstructured":"Schottel, B. L., Chifotides, H. T. & Dunbar, K. R. Anion-p interactions. Chem. Soc. Rev. 37, 68\u201383 (2008).","journal-title":"Chem. Soc. Rev."},{"issue":"6","key":"81711_CR89","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1021\/ar7000099","volume":"40","author":"P Gamez","year":"2007","unstructured":"Gamez, P., Mooibroek, T. J., Teat, S. J. & Reedijk, J. Anion binding involving pi-acidic heteroaromatic rings. Acc. Chem. Res. 40 (6), 435\u2013444 (2007).","journal-title":"Acc. Chem. Res."},{"issue":"2","key":"81711_CR90","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1021\/ja310834w","volume":"135","author":"DX Wang","year":"2013","unstructured":"Wang, D. X. & Wang, M. X. Anion-pi interactions: generality, binding strength, and structure. J. Am. Chem. Soc. 135 (2), 892\u2013897 (2013).","journal-title":"J. Am. Chem. Soc."},{"issue":"48","key":"81711_CR91","doi-asserted-by":"publisher","first-page":"16789","DOI":"10.1073\/pnas.0407607101","volume":"101","author":"P Auffinger","year":"2004","unstructured":"Auffinger, P. et al. Halogen bonds in biological molecules. Proc. Natl. Acad. Sci. U. S. A. 101 (48), 16789\u201316794 (2004).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"81711_CR92","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/acs.chemrev.5b00484","volume":"116","author":"G Cavallo","year":"2016","unstructured":"Cavallo, G. et al. The halogen bond. Chem. Rev. 116 (4), 2478\u20132601 (2016).","journal-title":"Chem. Rev."},{"issue":"4","key":"81711_CR93","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/prot.20015","volume":"55","author":"EI Howard","year":"2004","unstructured":"Howard, E. I. et al. Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A. Proteins 55 (4), 792\u2013804 (2004).","journal-title":"Proteins"},{"issue":"15","key":"81711_CR94","doi-asserted-by":"publisher","first-page":"8742","DOI":"10.1073\/pnas.1432955100","volume":"100","author":"N Muzet","year":"2003","unstructured":"Muzet, N. et al. Electrostatic complementarity in an aldose reductase complex from ultra-high-resolution crystallography and first-principles calculations. Proc. Natl. Acad. Sci. U. S. A. 100 (15), 8742\u20138747 (2003).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"81711_CR95","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/prot.10278","volume":"50","author":"O El-Kabbani","year":"2003","unstructured":"El-Kabbani, O. et al. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme. Proteins 50 (2), 230\u2013238 (2003).","journal-title":"Proteins"},{"issue":"4","key":"81711_CR96","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jksus.2019.01.011","volume":"34","author":"DE Arthur","year":"2019","unstructured":"Arthur, D. E. & Uzairu, A. Molecular docking studies on the interaction of NCI anticancer analogues with human phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit. J. King Saud Univ. Sci. 34 (4), 1151\u20131166 (2019).","journal-title":"J. King Saud Univ. \u2013 Sci."},{"key":"81711_CR97","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.pbiomolbio.2021.02.002","volume":"163","author":"CA Brosey","year":"2021","unstructured":"Brosey, C. A. et al. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors. Prog. Biophys. Mol. Biol. 163, 171\u2013186 (2021).","journal-title":"Prog Biophys. Mol. Biol."},{"key":"81711_CR98","doi-asserted-by":"crossref","unstructured":"Alhammad, Y. M. O. & Fehr, A. R. The viral macrodomain counters host antiviral ADP-ribosylation. Viruses 12 (4), 384 (2020).","DOI":"10.3390\/v12040384"},{"issue":"28","key":"81711_CR99","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1021\/acs.biochem.0c00309","volume":"59","author":"D Frick","year":"2020","unstructured":"Frick, D. et al. Molecular basis for ADP-ribose binding to the Mac1 domain of SARS-CoV-2 nsp3. Biochemistry 59 (28), 2608\u20132615 (2020).","journal-title":"Biochemistry"},{"key":"81711_CR100","doi-asserted-by":"publisher","first-page":"102899","DOI":"10.1016\/j.dnarep.2020.102899","volume":"94","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Molecular basis for the MacroD1-mediated hydrolysis of ADP-ribosylation. DNA Repair. (Amst.) 94, 102899 (2020).","journal-title":"DNA Repair. (Amst)"},{"key":"81711_CR101","doi-asserted-by":"crossref","unstructured":"Gahbauer, S. et al. Iterative computational design and crystallographic screening identifies potent inhibitors targeting the Nsp3 macrodomain of SARS-CoV-2. Proc. Natl. Acad. Sci. U. S. A.  120  (2) (2023).","DOI":"10.1073\/pnas.2212931120"},{"key":"81711_CR102","doi-asserted-by":"publisher","first-page":"1328128","DOI":"10.3389\/fphar.2024.1328128","volume":"15","author":"OM Alshehri","year":"2024","unstructured":"Alshehri, O. M. et al. Investigation of anti-nociceptive, anti-inflammatory potential and ADMET studies of pure compounds isolated from Isodon rugosus wall. ex Benth. Front. Pharmacol. 15, 1328128 (2024).","journal-title":"Front. Pharmacol."},{"issue":"21","key":"81711_CR103","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.3390\/molecules28217455","volume":"28","author":"MM Fakhry","year":"2023","unstructured":"Fakhry, M. M. et al. New thiazolyl-pyrazoline derivatives as potential dual EGFR\/HER2 inhibitors: design, synthesis, anticancer activity evaluation and in silico study. Molecules 28 (21), 7455 (2023).","journal-title":"Molecules"},{"issue":"2","key":"81711_CR104","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/molecules29020441","volume":"29","author":"M Latosi\u0144ska","year":"2024","unstructured":"Latosi\u0144ska, M. & Latosi\u0144ska, J. N. Favipiravir Analogues as inhibitors of SARS-CoV-2 RNA-dependent RNA polymerase, combined quantum chemical modeling, quantitative structure-property relationship, and molecular docking study. Molecules 29 (2), 441 (2024).","journal-title":"Molecules"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81711-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81711-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T09:02:09Z","timestamp":1735981329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-81711-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["81711"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-81711-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"8 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"767"}}